DALLAS, February 21, 2012 /PRNewswire/ --

The "Life Science and Chemical Instrumentation Market (2011 - 2016) (Spectroscopy, Chromatography, DNA Sequencer & Amplifier, Lab Automation, Array, Flow Cytometer, Electrophoresis, Immuno Assay & Others)" report analyzes and studies the major market drivers, restraints, and opportunities in regions such as U.S., Europe, Asia, and Rest of the world.

Browse market data tables and in-depth TOC on

"Life Science and Chemical Instrumentation Market (2011 - 2016) (Spectroscopy, Chromatography, DNA Sequencer & Amplifier, Lab Automation, Array, Flow Cytometer, Electrophoresis, Immuno Assay & Others)".
http://www.marketsandmarkets.com/Market-Reports/life-science-chemical-biotech-instrumentation-market-38.html
Early buyers will receive 10% customization on reports.

The global life science and instrumentation market was estimated to be $30.2 billion in the year 2011 and is expected to grow at a CAGR of 8.4% from 2011 to 2016 to reach $45.2 billion. Spectrometry segment has the largest share (33.8%) followed by chromatography (22%) in the year 2011. The spectrometry market is driven by the coupling of mass spectrometry with chromatography techniques, growing at a CAGR of 7.4% from 2011 to 2016.

Life Sciences and chemical instruments are used to:

• Develop new diagnostics, vaccines, and treatments to improve health
• Lift agricultural productivity
• Manage the environment through pollution and pest control and the use of organic materials to generate energy
• Assist with industrial innovation

Research and development is an essential part of life science and chemical industry. In the U.S., $25,101 million PPP (Purchasing Power Parity) was spend on the research and development by the biotechnology firms, in 2010. In the year 2008, the total biotechnology companies were 1,452 in the U.S. and increased by 17% to reach 1,699 in the year 2009. In 2008, 20% of pharmaceuticals were of biological origin, there are currently more than 200 biopharmaceutical drugs available in the market for treating 400 indications, and at the same time, 300 biopharmaceuticals are under clinical trials. These are the major factors driving the market.

The major players of Life Science and Chemical Instrumentation Market [ http://www.marketsandmarkets.com/Market-Reports/life-science-chemical-biotech-instrumentation-market-38.html ] include Affymetrix Inc. (U.S.), Illumina Inc. (U.S.), Agilent Technologies Inc. (U.S.), Roche Diagnostics Inc. (Switzerland), Bio-Rad Laboratories (U.S.), GE Healthcare (Sweden), Life Technologies (U.S.), Perkin Elmer (U.S.), Caliper Life Sciences (U.S.), Shimadzu Corporation (Japan), Abbott Laboratories (U.S.), Hitachi High-technologies Corporation (Japan), and Siemens Healthcare Diagnostics (Germany).

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology [ http://www.marketsandmarkets.com/biotech-market-research-5.html ], chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com.

Contact:
Mr. Rohan
7557 Rambler Road,
Suite 727, Dallas, TX 75231
Tel: +1-888-6006-441
Email: sales@marketsandmarkets.com
MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/
http://twitter.com/marketsmarkets

SOURCE MarketsandMarkets